| $350M | ||
| $172M | ||
| $127M | ||
| $109M | ||
| $107M | ||
| $100M |
Buys | $0 | 0 | 0 |
Sells | $32,731,558 | 7 | 100 |
| Wyatt Christopher F. | SVP & Controller | 0 | $0 | 1 | $2.02M | $-2.02M |
| Cuffe Michael S. | EVP and Chief Clinical Officer | 0 | $0 | 2 | $2.35M | $-2.35M |
| McAlevey Michael R | EVP & Chief Legal & Admin Off. | 0 | $0 | 2 | $2.75M | $-2.75M |
| Berres Jennifer | SVP & Chief Human Res. Officer | 0 | $0 | 1 | $4.13M | $-4.13M |
| HAZEN SAMUEL N | CEO | 0 | $0 | 1 | $21.48M | $-21.48M |
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.
Over the last 12 months, insiders at HCA Healthcare, Inc. have bought $0 and sold $32.73M worth of HCA Healthcare, Inc. stock.
On average, over the past 5 years, insiders at HCA Healthcare, Inc. have bought $3.17M and sold $30.5M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 325 shares for transaction amount of $64,565 was made by Elcan Patricia F () on 2022‑07‑25.
| 2026-02-18 | Sale | McAlevey Michael R | EVP & Chief Legal & Admin Off. | 1,694 0.0008% | $533.37 | $903,537 | -21.60% | |
| 2026-02-11 | Sale | Wyatt Christopher F. | SVP & Controller | 4,000 0.0017% | $505.00 | $2.02M | -20.58% | |
| 2026-02-11 | Sale | Berres Jennifer | SVP & Chief Human Res. Officer | 8,020 0.0034% | $514.58 | $4.13M | -20.58% | |
| 2026-02-03 | Sale | HAZEN SAMUEL N | CEO | 42,877 0.0189% | $501.04 | $21.48M | -14.71% | |
| 2026-02-03 | Sale | Cuffe Michael S. | EVP and Chief Clinical Officer | 1,500 0.0007% | $498.09 | $747,135 | -14.71% | |
| 2025-11-05 | Sale | McAlevey Michael R | EVP & Chief Legal & Admin Off. | 3,892 0.0017% | $473.79 | $1.84M | -0.51% | |
| 2025-09-08 | Sale | Cuffe Michael S. | EVP and Chief Clinical Officer | 3,836 0.0016% | $418.84 | $1.61M | +6.41% | |
| 2025-05-13 | Sale | Foster Jon M | EVP and COO | 15,698 0.0065% | $369.32 | $5.8M | +20.30% | |
| 2025-02-14 | Sale | Berres Jennifer | SVP & Chief Human Res. Officer | 9,533 0.0038% | $322.59 | $3.08M | +25.13% | |
| 2024-11-14 | Sale | Billington Phillip G | SVP-Internal Audit Services | 3,897 0.0016% | $350.00 | $1.36M | +3.55% | |
| 2024-11-14 | Sale | Whalen Kathleen M | SVP & Chief Ethics Officer | 1,474 0.0006% | $357.99 | $527,677 | +3.55% | |
| 2024-11-14 | Sale | Akdamar Erol R | Group President | 2,900 0.0012% | $353.00 | $1.02M | +3.55% | |
| 2024-09-12 | Sale | Cuffe Michael S. | EVP and Chief Clinical Officer | 8,358 0.0032% | $385.42 | $3.22M | -9.29% | |
| 2024-07-31 | Sale | Whalen Kathleen M | SVP & Chief Ethics Officer | 2,987 0.0011% | $363.51 | $1.09M | -2.88% | |
| 2024-07-29 | Sale | Wyatt Christopher F. | SVP & Controller | 4,000 0.0015% | $360.20 | $1.44M | -1.71% | |
| 2024-07-29 | Sale | Whalen Kathleen M | SVP & Chief Ethics Officer | 1,864 0.0007% | $359.92 | $670,891 | -1.71% | |
| 2024-07-29 | Sale | Reiner Deborah M | SVP - Mktg. & Communications | 3,314 0.0013% | $359.96 | $1.19M | -1.71% | |
| 2024-07-25 | Sale | Torres Kathryn A. | SVP-Payer Contracting & Align. | 1,857 0.0007% | $355.05 | $659,328 | +0.42% | |
| 2024-05-16 | Sale | Whalen Kathleen M | SVP & Chief Ethics Officer | 3,204 0.0012% | $326.30 | $1.05M | +4.64% | |
| 2024-05-15 | Sale | Torres Kathryn A. | SVP-Payer Contracting & Align. | 1,863 0.0007% | $326.18 | $607,673 | +3.24% |
| Wyatt Christopher F. | SVP & Controller | 44379 0.0205% | $17.97M | 0 | 10 | |
| HAZEN SAMUEL N | CEO | 32276 0.0149% | $13.07M | 0 | 14 | |
| Cuffe Michael S. | EVP and Chief Clinical Officer | 30003 0.0139% | $12.15M | 0 | 43 | |
| Berres Jennifer | SVP & Chief Human Res. Officer | 11993 0.0055% | $4.86M | 0 | 6 | |
| McAlevey Michael R | EVP & Chief Legal & Admin Off. | 8853 0.0041% | $3.59M | 1 | 2 | +2.53% |
| HERCULES HOLDING II, LLC | 10 percent owner | 99363755 45.8952% | $40.24B | 0 | 5 | |
| CONNAUGHTON JOHN | director | 35331374 16.3192% | $14.31B | 0 | 4 | |
| Gordon Christopher R | director | 35331374 16.3192% | $14.31B | 0 | 4 | |
| BAIN CAPITAL INVESTORS LLC | 10 percent owner | 30003156 13.8582% | $12.15B | 0 | 4 | |
| PAGLIUCA STEPHEN G | director | 15225842 7.0327% | $6.17B | 0 | 5 | |
| BANK OF AMERICA CORP /DE/ | 2652364 1.2251% | $1.07B | 45 | 51 | <0.0001% | |
| FRIST THOMAS F JR | 471378 0.2177% | $190.91M | 8 | 1 | +1.98% | |
| FRIST PATRICIA C | 10 percent owner | 389855 0.1801% | $157.89M | 5 | 0 | +7.64% |
| JOHNSON R MILTON | Chairman & CEO | 298775 0.138% | $121M | 0 | 6 | |
| BOVENDER JACK O JR | Chairman and CEO | 263370 0.1216% | $106.66M | 0 | 1 | |
| Rutledge W Paul | Group President | 263077 0.1215% | $106.55M | 0 | 4 | |
| Hall Charles J | Group President | 199883 0.0923% | $80.95M | 0 | 23 | |
| CAMPBELL VICTOR L | SVP-Government Affairs | 189868 0.0877% | $76.9M | 0 | 13 | |
| BRACKEN RICHARD M | President and COO | 130222 0.0601% | $52.74M | 0 | 8 | |
| ROYAL FRANK S | director | 97913 0.0452% | $39.65M | 0 | 2 | |
| ANDERSON DAVID GWIN | SVP - Finance | 94364 0.0436% | $38.22M | 0 | 22 | |
| Elcan Patricia F | 89337 0.0413% | $36.18M | 2 | 0 | +13.15% | |
| WALLACE BEVERLY B | President - NewCo Business | 85160 0.0393% | $34.49M | 0 | 7 | |
| STEELE JOHN M | SVP & Chief Human Res. Officer | 77734 0.0359% | $31.48M | 0 | 17 | |
| WILLIAMS NOEL B | SVP and CIO | 72065 0.0333% | $29.19M | 0 | 9 | |
| Vallarino Juan | SVP- Employer&Payer Engagement | 61036 0.0282% | $24.72M | 1 | 13 | <0.0001% |
| STEAKLEY JOSEPH N | SVP-Internal Audit Services | 56974 0.0263% | $23.07M | 0 | 13 | |
| Billington Phillip G | SVP-Internal Audit Services | 52702 0.0243% | $21.34M | 0 | 3 | |
| Stinnett Donald W | SVP & Controller | 52499 0.0242% | $21.26M | 0 | 8 | |
| WATERMAN ROBERT A | SVP & General Counsel | 50062 0.0231% | $20.28M | 0 | 17 | |
| KRAVIS HENRY R | 10 percent owner | 49200 0.0227% | $19.93M | 0 | 6 | |
| KKR Millennium Fund L.P. | 10 percent owner | 49200 0.0227% | $19.93M | 0 | 6 | |
| KKR PEI Investments, L.P. | 10 percent owner | 49200 0.0227% | $19.93M | 0 | 6 | |
| Evans Charles Robert | President - Eastern Group | 42834 0.0198% | $17.35M | 0 | 2 | |
| SHALLCROSS RICHARD J | CFO - Western Group | 42310 0.0195% | $17.14M | 0 | 4 | |
| ELTON ROSALYN S | SVP-Operations Finance | 39662 0.0183% | $16.06M | 0 | 4 | |
| HOUSER FRANK M MD | SVP-Quality & Medical Director | 38400 0.0177% | $15.55M | 0 | 7 | |
| GRINNEY JAY | President-Eastern Group | 37896 0.0175% | $15.35M | 0 | 3 | |
| GEORGE V CARL | SVP-Development | 36774 0.017% | $14.89M | 0 | 8 | |
| MOORE A BRUCE JR | Group President - Service Line | 30807 0.0142% | $12.48M | 0 | 24 | |
| LINDLER PATRICIA T | SVP - Government Programs | 26331 0.0122% | $10.66M | 0 | 6 | |
| Davis Jana Joustra | SVP - Mktg. & Corp. Affairs | 26378 0.0122% | $10.68M | 1 | 14 | <0.0001% |
| TAVENNER MARILYN B | President-Outpatient Svcs Grp | 25017 0.0116% | $10.13M | 0 | 7 | |
| Paslick P. Martin | SVP and CIO | 24643 0.0114% | $9.98M | 0 | 22 | |
| YUSPEH ALAN R | SVP & Chief Ethics Officer | 22656 0.0105% | $9.18M | 0 | 19 | |
| HANKINS ROBERT SAMUEL JR | CFO-Outpatient Services Group | 19862 0.0092% | $8.04M | 0 | 1 | |
| MEYERS GEOFFREY G | director | 19167 0.0089% | $7.76M | 1 | 0 | <0.0001% |
| ROWE JOHN W | director | 18133 0.0084% | $7.34M | 1 | 0 | +33.58% |
| Torres Kathryn A. | SVP-Payer Contracting & Align. | 17755 0.0082% | $7.19M | 0 | 21 | |
| ROTH GREG | President-Ambulatory Surgery | 15081 0.007% | $6.11M | 0 | 1 | |
| Light Jay O | director | 14167 0.0065% | $5.74M | 1 | 0 | <0.0001% |
| McManus Timothy M | Group President | 13987 0.0065% | $5.66M | 0 | 1 | |
| FITZGERALD JAMES A JR | SVP-Supply Chain Operations | 13843 0.0064% | $5.61M | 0 | 3 | |
| Crudele Jeffrey T | CFO-Eastern Division | 13833 0.0064% | $5.6M | 0 | 1 | |
| LONG T MICHAEL | director | 13378 0.0062% | $5.42M | 0 | 1 | |
| HATCHETT GLENDA A | director | 12650 0.0058% | $5.12M | 0 | 1 | |
| Foster Jon M | EVP and COO | 12646 0.0058% | $5.12M | 0 | 21 | |
| MCARTHUR JOHN H | director | 10818 0.005% | $4.38M | 0 | 1 | |
| Riley Wayne Joseph | director | 10819 0.005% | $4.38M | 0 | 5 | |
| Whalen Kathleen M | SVP & Chief Ethics Officer | 9454 0.0044% | $3.83M | 0 | 16 | |
| RUTHERFORD BILL B | CFO and EVP | 8448 0.0039% | $3.42M | 0 | 11 | |
| HOLLIDAY CHARLES O JR | director | 8000 0.0037% | $3.24M | 2 | 0 | <0.0001% |
| Mosier Sammie S | SVP & Chief Nurse Executive | 7646 0.0035% | $3.1M | 0 | 1 | |
| Akdamar Erol R | Group President | 6843 0.0032% | $2.77M | 0 | 3 | |
| AVERHOFF MAGDALENA MD | director | 6703 0.0031% | $2.71M | 0 | 1 | |
| Morgan Sandra L. | SVP-Provider Relations | 5598 0.0026% | $2.27M | 0 | 11 | |
| Cohen Jeffrey E. | SVP-Government Relations | 5185 0.0024% | $2.1M | 0 | 2 | |
| Reiner Deborah M | SVP - Mktg. & Communications | 3510 0.0016% | $1.42M | 0 | 15 | |
| Smith Andrea B | 2239 0.001% | $906,795.00 | 1 | 0 | +0.29% | |
| Wasserman Chad J | SVP and CIO | 1576 0.0007% | $638,405.63 | 0 | 3 | |
| Morrow J William | SVP - Finance and Treasurer | 1358 0.0006% | $550,080.52 | 0 | 7 | |
| Perlin Jonathan B | Pres-Clinical Operations & CMO | 0 0% | $0 | 0 | 30 | |
| Sowell Joseph A III | SVP; Chief Development Officer | 0 0% | $0 | 1 | 9 | <0.0001% |
| Chari Ravi S. | SVP-Clinical Excellence | 0 0% | $0 | 0 | 5 | |
| Englebright Jane D. | SVP and Chief Nursing Officer | 0 0% | $0 | 0 | 19 |
| Increased Positions | 688 | +47.94% | 9M | +6.32% |
| Decreased Positions | 618 | -43.07% | 12M | -8.44% |
| New Positions | 199 | New | 2M | New |
| Sold Out Positions | 86 | Sold Out | 1M | Sold Out |
| Total Postitions | 1,505 | +4.88% | 137M | -2.12% |
| Vanguard Group Inc | $7.01M | 6.53% | 14.89M | -580,889 | -3.75% | 2025-09-30 |
| Blackrock, Inc. | $5.86M | 5.47% | 12.47M | -483,554 | -3.73% | 2025-09-30 |
| Sanders Capital, Llc | $5.02M | 4.68% | 10.68M | -426,920 | -3.85% | 2025-09-30 |
| State Street Corp | $3.52M | 3.29% | 7.49M | -466,059 | -5.86% | 2025-09-30 |
| Capital World Investors | $2.33M | 2.17% | 4.96M | +179,443 | +3.75% | 2025-09-30 |
| First Eagle Investment Management, Llc | $1.84M | 1.72% | 3.92M | -290,385 | -6.9% | 2025-09-30 |
| Wellington Management Group Llp | $1.83M | 1.7% | 3.88M | -230,117 | -5.6% | 2025-09-30 |
| Geode Capital Management, Llc | $1.72M | 1.6% | 3.65M | -147,762 | -3.89% | 2025-09-30 |
| Norges Bank | $1.41M | 1.32% | 3.01M | +208,560 | +7.45% | 2025-06-30 |
| Jpmorgan Chase & Co | $1.41M | 1.31% | 2.99M | -292,265 | -8.91% | 2025-09-30 |